{"transactions":[{"id":3122858,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-04T17:50:16.000Z","date":"2020-06-03","kind":"sale","acquired":false,"shares":21932,"price":1.097,"value":24059.404,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reporting person is no longer a 10% Owner after the sale of the 21,932 shares reported on the transaction date. This filing also constitutes a Form 4 \"exit filing\" for the reporting person as the reporting person is no longer subject to Section 16 under the Securities Exchange Act of 1934, as amended, as of the date of this filing."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $1.00 to not more than $1.12. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the ranges set forth in the footnotes to this Form 4 that report a range of prices."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held of record by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":276100,"source":{"system":"sec-edgar","filing":"0001493152-20-010545","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220010545/ownership.xml","form_type":"4"}},{"id":3125914,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T16:01:54.000Z","date":"2020-06-02","kind":"sale","acquired":false,"shares":30730,"price":0.99,"value":30422.7,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $0.95 to not more than $1.05. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the ranges set forth in the footnotes to this Form 4 that report a range of prices."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":297440,"source":{"system":"sec-edgar","filing":"0001493152-20-010447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220010447/ownership.xml","form_type":"4"}},{"id":3125913,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T16:01:54.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":30000,"price":1.059,"value":31770.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $1.02 to not more than $1.08. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the ranges set forth in the footnotes to this Form 4 that report a range of prices."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":328170,"source":{"system":"sec-edgar","filing":"0001493152-20-010447","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220010447/ownership.xml","form_type":"4"}},{"id":3129883,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-01T13:32:55.000Z","date":"2020-05-29","kind":"sale","acquired":false,"shares":25000,"price":1.058,"value":26450.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $1.05 to not more than $1.12. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the ranges set forth in the footnotes to this Form 4 that report a range of prices."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":358170,"source":{"system":"sec-edgar","filing":"0001493152-20-010219","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220010219/ownership.xml","form_type":"4"}},{"id":3129882,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-06-01T13:32:55.000Z","date":"2020-05-28","kind":"sale","acquired":false,"shares":12338,"price":1.082,"value":13349.716,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $1.05 to not more than $1.17. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the ranges set forth in the footnotes to this Form 4 that report a range of prices."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":383170,"source":{"system":"sec-edgar","filing":"0001493152-20-010219","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220010219/ownership.xml","form_type":"4"}},{"id":3131479,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T10:11:58.000Z","date":"2020-05-27","kind":"sale","acquired":false,"shares":5000,"price":1.108,"value":5540.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $1.08 to not more than $1.13. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the ranges set forth in the footnotes to this Form 4 that report a range of prices."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":395508,"source":{"system":"sec-edgar","filing":"0001493152-20-010087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220010087/ownership.xml","form_type":"4"}},{"id":3131478,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T10:11:58.000Z","date":"2020-05-26","kind":"sale","acquired":false,"shares":20000,"price":1.089,"value":21780.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $1.07 to not more than $1.16. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the ranges set forth in the footnotes to this Form 4 that report a range of prices."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":400508,"source":{"system":"sec-edgar","filing":"0001493152-20-010087","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315220010087/ownership.xml","form_type":"4"}},{"id":3331970,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-26T21:30:23.000Z","date":"2019-12-23","kind":"sale","acquired":false,"shares":200,"price":2.45,"value":490.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":421100,"source":{"system":"sec-edgar","filing":"0001493152-19-019726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219019726/ownership.xml","form_type":"4"}},{"id":3331969,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-26T21:30:23.000Z","date":"2019-12-20","kind":"sale","acquired":false,"shares":1700,"price":2.72,"value":4624.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $2.57 to not more than $2.87. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the ranges set forth in the footnotes to this Form 4 that report a range of prices."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held of record by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":421300,"source":{"system":"sec-edgar","filing":"0001493152-19-019726","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315219019726/ownership.xml","form_type":"4"}},{"id":4196581,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-03T20:15:21.000Z","date":"2017-09-29","kind":"grant","acquired":true,"shares":919,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock grant was issued to the reporting person under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan and pursuant to the NTN Buzztime, Inc. Non-Employee Director Compensation Policy in lieu of a portion of the annual retainer earned by the reporting person in his capacity as a non-employee director of the issuer with respect to the quarter ended September 30, 2017. This restricted stock grant was fully-vested on the date of grant."}],"balance_after":12346,"source":{"system":"sec-edgar","filing":"0001493152-17-011198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315217011198/form4.xml","form_type":"4"}},{"id":4266755,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-07-05T22:02:13.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":827,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This restricted stock grant was issued to the reporting person under the NTN Buzztime, Inc. Amended 2010 Performance Incentive Plan and pursuant to the NTN Buzztime, Inc. Non-Employee Director Compensation Policy in lieu of a portion of the annual retainer earned by the reporting person in his capacity as a non-employee director of the issuer. This restricted stock grant was fully-vested on the date of grant."}],"balance_after":11427,"source":{"system":"sec-edgar","filing":"0001493152-17-007505","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315217007505/form4.xml","form_type":"4"}},{"id":4554163,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T01:29:37.000Z","date":"2016-11-16","kind":"purchase","acquired":true,"shares":500,"price":7.25,"value":3625.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":423000,"source":{"system":"sec-edgar","filing":"0001493152-16-015198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216015198/form4.xml","form_type":"4"}},{"id":4554162,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T01:29:37.000Z","date":"2016-11-16","kind":"purchase","acquired":true,"shares":500,"price":7.28,"value":3640.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":422500,"source":{"system":"sec-edgar","filing":"0001493152-16-015198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216015198/form4.xml","form_type":"4"}},{"id":4554161,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T01:29:37.000Z","date":"2016-11-16","kind":"purchase","acquired":true,"shares":720,"price":7.26,"value":5227.2,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":422000,"source":{"system":"sec-edgar","filing":"0001493152-16-015198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216015198/form4.xml","form_type":"4"}},{"id":4554160,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T01:29:37.000Z","date":"2016-11-16","kind":"purchase","acquired":true,"shares":1000,"price":7.23,"value":7230.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":421280,"source":{"system":"sec-edgar","filing":"0001493152-16-015198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216015198/form4.xml","form_type":"4"}},{"id":4554159,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T01:29:37.000Z","date":"2016-11-16","kind":"purchase","acquired":true,"shares":1200,"price":7.21,"value":8652.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":420080,"source":{"system":"sec-edgar","filing":"0001493152-16-015198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216015198/form4.xml","form_type":"4"}},{"id":4554158,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T01:29:37.000Z","date":"2016-11-15","kind":"purchase","acquired":true,"shares":500,"price":7.33,"value":3665.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":419080,"source":{"system":"sec-edgar","filing":"0001493152-16-015198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216015198/form4.xml","form_type":"4"}},{"id":4554157,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":148705,"kind":"person","name":"Berg Jeffrey Alan","position":1,"cik":"0001443481","reported_name":"Berg Jeffrey Alan","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2016-11-17T01:29:37.000Z","date":"2016-11-14","kind":"purchase","acquired":true,"shares":1200,"price":7.2,"value":8640.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These securities are owned by Matador Capital Partners, L.P. The reporting person is the managing member of BFK Investments LLC, which is the general partner of Matador Capital Partners, L.P. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein."}],"balance_after":418580,"source":{"system":"sec-edgar","filing":"0001493152-16-015198","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000149315216015198/form4.xml","form_type":"4"}}]}